CEL-SCI Co. (NYSEAMERICAN:CVM) saw a large growth in short interest during the month of January. As of January 12th, there was short interest totalling 759,737 shares, a growth of 48.9% from the December 29th total of 510,101 shares.
It provides information on trends and developments, focuses on markets and materials, capacities, technologies, CAPEX cycle and the changing structure of the Global West Nile Virus Infections Medicine Market.
CEL-SCI Co. (NYSEAMERICAN:CVM) saw a significant decline in short interest during the month of December. As of December 29th, there was short interest totalling 510,101 shares, a decline of 3.2% from the December 15th total of 526,760 shares.
The research covers the current market size of the Global Poxviridae Infections Drug market and its growth rates based on 5 year history data along with company profile of key players/manufacturers such as Bavarian Nordic A/S, BioFactura, Inc., CEL-SCI ...